M. Silverman

发表

Progesterone supplementation for HIV-positive pregnant women on protease inhibitor-based antiretroviral regimens (the ProSPAR study): a study protocol for a pilot randomized controlled trial

M. Loutfy, L. Serghides, J. Raboud, 2016, Pilot and Feasibility Studies.

Leukocyte Telomere Length at Birth and During the Early Life of Children Exposed to but Uninfected With HIV After In Utero Exposure to Antiretrovirals

J. Singer, M. Smith, J. Brophy, 2018, The Journal of infectious diseases.

A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe.

R. Glazier, T. Chipato, A. Simor, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Perceived acceptability of progesterone to prevent preterm births and low birth weight among HIV-infected and HIV-uninfected Zambian pregnant women

L. Serghides, M. Silverman, N. Dogra, 2017, International journal of women's health.

Low Prolactin and High 20-α-Hydroxysteroid Dehydrogenase Levels Contribute to Lower Progesterone Levels in HIV-Infected Pregnant Women Exposed to Protease Inhibitor-Based Combination Antiretroviral Therapy.

M. Loutfy, L. Serghides, S. Walmsley, 2016, The Journal of infectious diseases.

Highly active anti-retroviral therapy in the prevention of mother-to-child transmission of HIV in rural Zimbabwe during the socio-economic crisis

E. Lam, A. Simor, S. Bolotin, 2011, Medicine, conflict, and survival.

Estradiol Levels Are Altered in Human Immunodeficiency Virus–Infected Pregnant Women Randomized to Efavirenz-Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy

K. Kain, A. Conroy, L. Serghides, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Conundrum of Low COVID-19 Mortality Burden in sub-Saharan Africa: Myth or Reality?

A. Ziraba, S. Stranges, A. Amegah, 2021, Global Health: Science and Practice.

HIV Protease Inhibitor Use During Pregnancy Is Associated With Decreased Progesterone Levels, Suggesting a Potential Mechanism Contributing to Fetal Growth Restriction

M. Loutfy, L. Serghides, S. Walmsley, 2014, The Journal of infectious diseases.

Elevated Blood Mitochondrial DNA in Early Life Among Uninfected Children Exposed to Human Immunodeficiency Virus and Combination Antiretroviral Therapy in utero

J. Singer, J. Brophy, N. Lapointe, 2020, The Journal of Infectious Diseases.

Increased Incidence of Tuberculosis in Zimbabwe, in Association with Food Insecurity, and Economic Collapse: An Ecological Analysis

R. Barker, A. Simor, S. Bolotin, 2014, PloS one.

Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011.

G. Tyrrell, I. Kitai, D. Low, 2013, Vaccine.

Elevated Levels of Estradiol in Human Immunodeficiency Virus–Infected Pregnant Women on Protease Inhibitor–Based Regimens

M. Loutfy, L. Serghides, S. Walmsley, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A randomized control trial of an Ultra-Short zidovudine regimen in the prevention of perinatal HIV transmission in rural Zimbabwe.

R. Glazier, A. Simor, R. Pilon, 2004, The Central African journal of medicine.

Evaluation of new anti-infective drugs for the treatment of syphilis. Infectious Diseases Society of America and the Food and Drug Administration.

H. Handsfield, J. McCutchan, L. Corey, 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Factors Associated With 30-Day Mortality Rate in Respiratory Infections Caused by Streptococcus pneumoniae

K. S. Lee, Aurora J. Wilson, I. Bogoch, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.